Biotech · Private company
NanOlogy, LLC
Track this companyFree. Adds NanOlogy, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials80 recruiting or active
Pipeline programs13From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline13
- NanoDoce (direct injection)Phase 2 · Bladder CancerClinicalTrials.gov · fetched Nov 12, 2026
- NanoDoce (intravesical instillation) - Induction and Maintenance InstillationsPhase 2 · Bladder CancerClinicalTrials.gov · fetched Nov 12, 2026
- NanoDoce (intravesical instillation) - Visit 2 InstillationPhase 2 · Bladder CancerClinicalTrials.gov · fetched Nov 12, 2026
- NanoPac (sterile nanoparticulate paclitaxel) Powder for SuspensionPhase 2 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- NanoPac (sterile nanoparticulate paclitaxel) Powder for SuspensionPhase 2 · Lung Cancer, Nonsmall CellClinicalTrials.gov · fetched Nov 12, 2026
- NanoPac®Phase 2 · Pancreatic Mucinous-Cystic NeoplasmClinicalTrials.gov · fetched Nov 12, 2026
- NanoPac®Phase 2 · Adenocarcinoma of the ProstateClinicalTrials.gov · fetched Nov 12, 2026
- NanoPac®Phase 2 · Locally Advanced Pancreatic AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- NanoPac® 100 mg/m2Phase 2 · Ovarian CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- NanoPac® 200 mg/m2Phase 2 · Ovarian CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- NanoPac® 300 mg/m2Phase 2 · Ovarian CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- NanoPac® 400 mg/m2Phase 2 · Ovarian CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- SOR007 (Uncoated Nanoparticle Paclitaxel) OintmentPhase 2 · Cutaneous MetastasisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- Trial of NanoPac Intratumoral Injection in Lung CancerPHASE2 · COMPLETED · started Apr 14, 2021ClinicalTrials.gov NCT04314895 · fetched Nov 12, 2026
- Trial of NanoPac Focal Therapy for Prostate CancerPHASE2 · TERMINATED · started Oct 20, 2020ClinicalTrials.gov NCT04221828 · fetched Nov 12, 2026
- Evaluation of NanoDoce® in Participants With Urothelial CarcinomaPHASE1_PHASE2 · COMPLETED · started Apr 2, 2019ClinicalTrials.gov NCT03636256 · fetched Nov 12, 2026
- Study of Topical SOR007 Ointment for Cutaneous MetastasesPHASE1_PHASE2 · COMPLETED · started Jan 31, 2018ClinicalTrials.gov NCT03101358 · fetched Nov 12, 2026
- Trial of NanoPac® in Subjects With Locally Advanced Pancreatic AdenocarcinomaPHASE2 · COMPLETED · started Dec 1, 2017ClinicalTrials.gov NCT03077685 · fetched Nov 12, 2026
- Intracystic Injection of NanoPac® in Subjects With Mucinous Cystic Pancreatic NeoplasmsPHASE2 · COMPLETED · started Sep 29, 2017ClinicalTrials.gov NCT03188991 · fetched Nov 12, 2026
- Trial of NanoPac® Focal Therapy in Subjects With Prostate CancerPHASE2 · COMPLETED · started Sep 6, 2017ClinicalTrials.gov NCT03077659 · fetched Nov 12, 2026
- Phase II Study of Intraperitoneal NanoPac® in Patients With Ovarian CancerPHASE2 · TERMINATED · started Apr 19, 2017ClinicalTrials.gov NCT03029585 · fetched Nov 12, 2026